Cantab Capital Partners, the systematic global macro manager, has named Dr Matthew Killeya (senior scientist) and Dr Genia Diamond (head of business development) as partners in the firm.
Diamond has lead the investor relations team that has overseen Cantab’s assets increase fivefold to USD5.3bn since 2011.
Killeya’s primary focus is on investment strategy development, having contributed strategies in all three of the clusters within the portfolio (momentum, value and short term).
Dr Ewan Kirk says: “Our investors know that we take both our investment models and investor relations immensely seriously. Both Genia and Matthew have contributed significantly to these respective functions, as well as the overall development of Cantab. As a result we are truly pleased they have accepted our offer to join the partnership.”
